02 Apr, 2014The Biotech Startup Incubator Boom


There’s a new trend in the biotech startup world, and that’s the increasing presence of biotech startup incubators across the country. Many scientists…

Read More

31 Mar, 2014Assay Depot Raises $3 million in Series B Funding


Assay Depot released a press release announcing it raised $3 million in Series B Funds to “Grow Science as a Server” Platform. Assay…

Read More

24 Mar, 2014Experiment.com: Crowdfunding science research


The increasing awareness of the scientific research community on the importance of open access and open science has given rise to a new…

Read More

20 Mar, 2014The Trials of Rare Disease Clinical Research


While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of potential rare disease…

Read More

18 Mar, 2014Computational Drug Discovery: Clinical Translation


Computational drug discovery has reduced the time and money required for research and development while increasing the potential number of drug leads in…

Read More

12 Mar, 2014Race to Cure Rare Diseases


Last year, Assay Depot announced our winners for the Rare Disease Challenge, as part of our efforts to raise awareness for rare diseases….

Read More

10 Mar, 2014Computational Drug Discovery: Increased Applications


We previously discussed how there are software methods to screen for potential drug leads and researchers have been able to increase their drug…

Read More

06 Mar, 2014CDD’s 10th Anniversary Community Meeting: Celebrating 10 Years of Collaborative Drug Discovery


Collaborative Drug Discovery (CDD) is hosting their users and community meeting at the UCSF Mission Bay Conference Center in San Francisco on Friday…

Read More

26 Feb, 2014Computational Drug Discovery: Technologies and Methods


Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery typically uses…

Read More

18 Feb, 2014Computational Drug Discovery: Traditional Methods Aren’t Enough!


Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope with tight margins…

Read More